DE60205481D1 - Furan and thiophen derivate die menschliche peroxisome proliferator aktivierte receptoren aktivieren - Google Patents
Furan and thiophen derivate die menschliche peroxisome proliferator aktivierte receptoren aktivierenInfo
- Publication number
- DE60205481D1 DE60205481D1 DE60205481T DE60205481T DE60205481D1 DE 60205481 D1 DE60205481 D1 DE 60205481D1 DE 60205481 T DE60205481 T DE 60205481T DE 60205481 T DE60205481 T DE 60205481T DE 60205481 D1 DE60205481 D1 DE 60205481D1
- Authority
- DE
- Germany
- Prior art keywords
- furan
- peroxisome proliferator
- activated receptors
- proliferator activated
- human peroxisome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0111523 | 2001-05-11 | ||
GBGB0111523.7A GB0111523D0 (en) | 2001-05-11 | 2001-05-11 | Chemical compounds |
PCT/GB2002/002152 WO2002092590A1 (en) | 2001-05-11 | 2002-05-09 | Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60205481D1 true DE60205481D1 (de) | 2005-09-15 |
DE60205481T2 DE60205481T2 (de) | 2006-05-24 |
Family
ID=9914442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60205481T Expired - Fee Related DE60205481T2 (de) | 2001-05-11 | 2002-05-09 | Furan and thiophen-derivate die menschliche peroxisome proliferator aktivierte rezeptoren aktivieren |
Country Status (20)
Country | Link |
---|---|
US (1) | US7091237B2 (de) |
EP (1) | EP1392674B1 (de) |
JP (1) | JP2004534035A (de) |
KR (1) | KR20040023600A (de) |
CN (1) | CN1507442A (de) |
AT (1) | ATE301649T1 (de) |
BR (1) | BR0209468A (de) |
CA (1) | CA2446797A1 (de) |
CO (1) | CO5540343A2 (de) |
CZ (1) | CZ20033064A3 (de) |
DE (1) | DE60205481T2 (de) |
ES (1) | ES2247322T3 (de) |
GB (1) | GB0111523D0 (de) |
HU (1) | HUP0304051A3 (de) |
IL (1) | IL158332A0 (de) |
MX (1) | MXPA03010285A (de) |
NO (1) | NO20034986L (de) |
PL (1) | PL367478A1 (de) |
WO (1) | WO2002092590A1 (de) |
ZA (1) | ZA200308352B (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
GB0113232D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical process |
JP4421895B2 (ja) | 2001-08-10 | 2010-02-24 | 日本ケミファ株式会社 | ペルオキシソーム増殖剤応答性受容体δの活性化剤 |
ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
US20030207924A1 (en) * | 2002-03-07 | 2003-11-06 | Xue-Min Cheng | Compounds that modulate PPAR activity and methods of preparation |
US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
US6875780B2 (en) | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
EP1535915A4 (de) * | 2002-09-06 | 2005-10-05 | Takeda Pharmaceutical | Furan- oder thiophenderivat und dessen medizinische verwendung |
JP2005035966A (ja) * | 2002-09-06 | 2005-02-10 | Takeda Chem Ind Ltd | フランまたはチオフェン誘導体およびその医薬用途 |
CA2505322A1 (en) * | 2002-11-08 | 2004-05-21 | Takeda Pharmaceutical Company Limited | Receptor function regulator |
AU2003296402A1 (en) * | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Thiophene derivative ppar modulators |
US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
EP1493739A1 (de) * | 2003-07-03 | 2005-01-05 | Warner-Lambert Company LLC | Thiophenderivate von Aminosäuren, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen |
EP2314576A1 (de) | 2003-11-05 | 2011-04-27 | F.Hoffmann-La Roche Ag | Phenylderivate zur Verwendung als PPAR-Agonisten |
US7456218B2 (en) | 2003-12-25 | 2008-11-25 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
WO2005063725A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | フェニルプロパン酸誘導体 |
GB0403148D0 (en) * | 2004-02-12 | 2004-03-17 | Smithkline Beecham Corp | Chemical compounds |
EP1586573B1 (de) | 2004-04-01 | 2007-02-07 | Sanofi-Aventis Deutschland GmbH | Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika |
CN101166720A (zh) * | 2005-02-28 | 2008-04-23 | 日本化学医药株式会社 | 过氧化物酶体增殖剂激活受体δ的激活剂 |
WO2006121223A1 (en) * | 2005-05-07 | 2006-11-16 | Heon Joong Kang | Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same |
CN101228144A (zh) * | 2005-05-25 | 2008-07-23 | 日本化学医药株式会社 | 过氧化物酶体增殖剂激活受体的激活剂 |
WO2007039178A2 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
NZ566877A (en) | 2005-09-29 | 2010-05-28 | Sanofi Aventis | Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
US20090012133A1 (en) * | 2006-01-10 | 2009-01-08 | Smithkline Beecham Corporation | Polymorphic Form of -Acetic Acid |
NZ572268A (en) | 2006-04-18 | 2011-09-30 | Nippon Chemiphar Co | Activating agent for peroxisome proliferator activated receptor delta (ppar) |
RS52575B (en) * | 2006-08-22 | 2013-04-30 | Ranbaxy Laboratories Limited | PROCEDURE FOR THE MAKING OF MATRIX METALOPROTEINASE INHIBITORS AND THEIR CHIRAL ASSISTANTS |
FR2910894A1 (fr) * | 2006-12-29 | 2008-07-04 | Genfit Sa | Derives de 3-phenyl-1-(phenylthienyl)propan-1-one et de 3-phenyl-1-(phenylfuranyl)propan-1-one substitues, preparation et utilisation. |
AU2007341981A1 (en) | 2006-12-29 | 2008-07-10 | The Salk Institute For Biological Studies | Methods for enhancing exercise performance |
WO2008103574A2 (en) * | 2007-02-23 | 2008-08-28 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
US20100063041A1 (en) * | 2007-03-07 | 2010-03-11 | Ho-Sang Moon | Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same |
DE102008007400A1 (de) * | 2008-02-04 | 2009-08-06 | Bayer Healthcare Ag | Substituierte Furane und ihre Verwendung |
HUE039145T2 (hu) | 2008-04-15 | 2018-12-28 | Nippon Chemiphar Co | Aktivátor peroxim proliferátor-aktivált receptorhoz |
CN101643451B (zh) * | 2008-08-07 | 2013-03-06 | 浙江海正药业股份有限公司 | 过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法 |
AU2011296737A1 (en) | 2010-08-31 | 2013-04-11 | Snu R&Db Foundation | Use of the fetal reprogramming of a PPAR delta agonist |
KR102194088B1 (ko) * | 2013-03-14 | 2020-12-22 | 다우 아그로사이언시즈 엘엘씨 | 특정 살충 유용성을 갖는 분자, 및 그와 관련된 중간체, 조성물 및 방법 |
ES2690145T3 (es) * | 2013-03-14 | 2018-11-19 | Janssen Pharmaceutica Nv | Agonistas de GPR120 para el tratamiento de diabetes de tipo 2 |
US11634387B2 (en) | 2019-09-26 | 2023-04-25 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
WO2022189856A1 (en) * | 2021-03-08 | 2022-09-15 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
HUP0201291A3 (en) * | 1999-04-28 | 2002-11-28 | Sanofi Aventis Deutschland | Di-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them |
-
2001
- 2001-05-11 GB GBGB0111523.7A patent/GB0111523D0/en not_active Ceased
-
2002
- 2002-05-09 JP JP2002589475A patent/JP2004534035A/ja active Pending
- 2002-05-09 EP EP02722506A patent/EP1392674B1/de not_active Expired - Lifetime
- 2002-05-09 WO PCT/GB2002/002152 patent/WO2002092590A1/en active IP Right Grant
- 2002-05-09 BR BR0209468-1A patent/BR0209468A/pt not_active IP Right Cessation
- 2002-05-09 ES ES02722506T patent/ES2247322T3/es not_active Expired - Lifetime
- 2002-05-09 KR KR10-2003-7014660A patent/KR20040023600A/ko not_active Application Discontinuation
- 2002-05-09 HU HU0304051A patent/HUP0304051A3/hu unknown
- 2002-05-09 PL PL02367478A patent/PL367478A1/xx not_active Application Discontinuation
- 2002-05-09 AT AT02722506T patent/ATE301649T1/de not_active IP Right Cessation
- 2002-05-09 CA CA002446797A patent/CA2446797A1/en not_active Abandoned
- 2002-05-09 MX MXPA03010285A patent/MXPA03010285A/es unknown
- 2002-05-09 DE DE60205481T patent/DE60205481T2/de not_active Expired - Fee Related
- 2002-05-09 IL IL15833202A patent/IL158332A0/xx unknown
- 2002-05-09 CZ CZ20033064A patent/CZ20033064A3/cs unknown
- 2002-05-09 CN CNA028096940A patent/CN1507442A/zh active Pending
- 2002-05-09 US US10/476,194 patent/US7091237B2/en not_active Expired - Fee Related
-
2003
- 2003-10-27 ZA ZA200308352A patent/ZA200308352B/en unknown
- 2003-11-10 CO CO03099078A patent/CO5540343A2/es not_active Application Discontinuation
- 2003-11-10 NO NO20034986A patent/NO20034986L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB0111523D0 (en) | 2001-07-04 |
CZ20033064A3 (cs) | 2004-02-18 |
BR0209468A (pt) | 2004-08-03 |
PL367478A1 (en) | 2005-02-21 |
ZA200308352B (en) | 2005-01-27 |
EP1392674A1 (de) | 2004-03-03 |
KR20040023600A (ko) | 2004-03-18 |
IL158332A0 (en) | 2004-05-12 |
WO2002092590A1 (en) | 2002-11-21 |
HUP0304051A3 (en) | 2005-11-28 |
JP2004534035A (ja) | 2004-11-11 |
CA2446797A1 (en) | 2002-11-21 |
DE60205481T2 (de) | 2006-05-24 |
ATE301649T1 (de) | 2005-08-15 |
HUP0304051A2 (hu) | 2004-04-28 |
US7091237B2 (en) | 2006-08-15 |
ES2247322T3 (es) | 2006-03-01 |
NO20034986D0 (no) | 2003-11-10 |
US20040157890A1 (en) | 2004-08-12 |
MXPA03010285A (es) | 2004-03-09 |
EP1392674B1 (de) | 2005-08-10 |
NO20034986L (no) | 2003-11-10 |
CO5540343A2 (es) | 2005-07-29 |
CN1507442A (zh) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60205481D1 (de) | Furan and thiophen derivate die menschliche peroxisome proliferator aktivierte receptoren aktivieren | |
DK1452524T3 (da) | "2-oxo-1-pyrrolidinderivat og dets farmaceutiske anvendelser" | |
PT1349843E (pt) | Derivados de tiazolo e de oxazolo como activadores dos receptores activados por proliferadores de peroxissomas humanos | |
TW200716520A (en) | 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | |
HRP20090281T1 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
TW200716572A (en) | Peroxisome proliferator activated receptor alpha agonists | |
BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
NO20035367D0 (no) | Modulatorer av peroksisomproliferatoraktiverte reseptorer (PPAR) | |
EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
CY1111851T1 (el) | Αρωματικες ενωσεις ως αντι-φλεγμονωδεις, ανοσορυθμιστικοι και αντι-πολλαπλασιαστικοι παραγοντες | |
DE602005011267D1 (de) | Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen | |
MY129310A (en) | C-4 carbonate taxanes | |
ATE296801T1 (de) | Tetrahydrobezindol derivate | |
ATE360428T1 (de) | Analgetisches arzneimittel | |
BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
SE9900438D0 (sv) | The pharmacological use of certian cystine derivatives | |
DOP2002000326A (es) | Utilizacion de cromanos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |